| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20015299 | HPV | ENSG00000186350.12 | protein_coding | RXRA | No | No | 6256 | P19793 Q6P3U7 |
| TVIS20067886 | HPV | ENSG00000186350.12 | protein_coding | RXRA | No | No | 6256 | P19793 Q6P3U7 |
| TVIS20015177 | HPV | ENSG00000186350.12 | protein_coding | RXRA | No | No | 6256 | P19793 Q6P3U7 |
| TVIS20026584 | HPV | ENSG00000186350.12 | protein_coding | RXRA | No | No | 6256 | P19793 Q6P3U7 |
| TVIS20016513 | HPV | ENSG00000186350.12 | protein_coding | RXRA | No | No | 6256 | P19793 Q6P3U7 |
| TVIS20030798 | HPV | ENSG00000186350.12 | protein_coding | RXRA | No | No | 6256 | P19793 Q6P3U7 |
| TVIS44020094 | HTLV-1 | ENSG00000186350.12 | protein_coding | RXRA | No | No | 6256 | P19793 Q6P3U7 |
| TVIS44022969 | HTLV-1 | ENSG00000186350.12 | protein_coding | RXRA | No | No | 6256 | P19793 Q6P3U7 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | RXRA |
|---|---|
| DrugBank ID | DB04557 |
| Drug Name | Arachidonic Acid |
| Target ID | BE0000412 |
| UniProt ID | P19793 |
| Regulation Type | |
| PubMed IDs | 15073272 |
| Citations | Lengqvist J, Mata De Urquiza A, Bergman AC, Willson TM, Sjovall J, Perlmann T, Griffiths WJ: Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor alpha ligand-binding domain. Mol Cell Proteomics. 2004 Jul;3(7):692-703. Epub 2004 Apr 8. |
| Groups | Experimental |
| Direct Classification | Long-chain fatty acids |
| SMILES | CCCCCC=C/CC=C/CC=C/CC=C/CCCC(O)=O |
| Pathways | Arachidonic Acid Metabolism; Flurbiprofen Action Pathway; Rofecoxib Action Pathway; Ketoprofen Action Pathway; Sulindac Action Pathway; Fenoprofen Action Pathway; Piroxicam Action Pathway; Nabumetone Action Pathway; Tolmetin Action Pathway; Lornoxicam Action Pathway; Trisalicylate-Choline Action Pathway; Antrafenine Action Pathway; Celecoxib Action Pathway; Suprofen Action Pathway; Indomethacin Action Pathway; Valdecoxib Action Pathway; Ketorolac Action Pathway; Acetylsalicylic Acid Action Pathway; Antipyrine Action Pathway; Tiaprofenic Acid Action Pathway; Alpha Linolenic Acid and Linoleic Acid Metabolism; Ibuprofen Action Pathway; Tenoxicam Action Pathway; Salicylic Acid Action Pathway; Diclofenac Action Pathway; Nepafenac Action Pathway; Leukotriene C4 Synthesis Deficiency; Magnesium Salicylate Action Pathway; Diflunisal Action Pathway; Etodolac Action Pathway |
| PharmGKB | |
| ChEMBL | CHEMBL15594 |
